Abstract
The greater part of the early literature on risks associated with cough medicines during pregnancy are case-control studies with a risk for various types of bias. The present prospective Swedish data give no reasons to expect any teratogenic effects, at least not from the drugs which have been used in Sweden during the past two decades. Data on components in traditional medicine are nearly totally lacking. Even though it is unlikely that they are teratogenic, it may be wise to avoid such drugs during pregnancy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bártfai Z, Somoskövi A, Puhó EH, Czeizel AE. No teratogenic effect of prenoxdiazine: a population-based case-control study. Congenit Anom. 2007;47:16–21.
Bateman DN, McElhatton PR, Dickison D, Wren C, Matthews JN, O’Keefe M, Thomas SH. A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. Eur J Clin Pharmacol. 2004;60:638–41.
Choi JS, Han JY, Ahn HK, Ryu HM, Kim MY, Chung JH, Nava-Ocampo AA, Koren G. Fetal and neonatal outcomes in women reporting ingestion of licorice (Glycyrrhiza uralensis) during pregnancy. Planta Med. 2013;79:97–101.
Einarson A, Lyszkiewicz D, Koren G. The safety of dextromethorphan in pregnancy. Chest. 2001;119:466–9.
Gallo M, Sarkar M, Au W, Pietrzak K, Comas B, Smith M, Jaeger TV, Einarson A, Koren G. Pregnancy outcome following gestational exposure to Echinacea: a prospective controlled study. Arch Intern Med. 2000;160:3141–3.
Giveb JE, Loane M, Garne E, Nelen V, Barisic I, Randrianaivo H, Khoshnood B, Wiesel A, Rissman A, Lynch C, Neville AJ, Pierini A, Bekker M, Klungsoyr K, Latos Bielenska A, Cavero-Carbonell C, Addor MC, Zymak-Zakutnya N, Tucker D, Dolk H. Gastroschisis in Europe—a case-malformed-control study of medication and maternal illness during pregnancy as risk factors. Paediatr Perinat Epidemiol. 2017;31:549–59.
Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group; 1977.
Martínez-Frías M-L, Rodriguez-Pinilla E. Epidemiological analysis of prenatal exposure to cough medicines containing dextromethorphan: no evidence of human teratogenicity. Teratology. 2001;63:38–41.
Shaw GM, Todoroff K, Velie EM, Lammer EJ. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology. 1998;57:1–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Källén, B. (2019). Maternal Use of Cough or Common Cold Medicine and Infant Congenital Malformations. In: Maternal Drug Use and Infant Congenital Malformations. Springer, Cham. https://doi.org/10.1007/978-3-030-17898-7_32
Download citation
DOI: https://doi.org/10.1007/978-3-030-17898-7_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17897-0
Online ISBN: 978-3-030-17898-7
eBook Packages: MedicineMedicine (R0)